Psyence BioMed Approves 2026 Financial Strategy, Board Authorizes Share Buyback on Value Opportunity
Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today ...
Snow Lake Resources Ltd., d/b/a Snow Lake Energy (NASDAQ: LITM) ("Snow Lake"), a nuclear fuel cycle company, announces that ...
Spec-Bench is a comprehensive benchmark designed for assessing Speculative Decoding methods across diverse scenarios. Based on Spec-Bench, we aim to establish and maintain a unified evaluation ...
The top Republican in the Michigan Senate is requesting an audit of the state’s Child Development and Care Program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results